|Gefen Biomed Investments Ltd -- Israel Stock|| |
ILS 4.8 0.00 0.00%
Mr. Gal Dikshtein was appointed Independent Director at Gefen Biomed Investments Ltd effective May 11, 2015. His work experience includes the following roles Owner and General Manager of his Own Consultancy firm from 2013 and Manager at Israel Tax Agency for four and a half years. He holds a Bachelors degree in Accounting and Economics from Rupin College and a MBA degree, majoring in Finance, from The Hebrew University of Jerusalem.
Age: 35 Director Since 2015 MBA
972 8 675 1122 http://www.gefenbiomed.com
The company has return on total asset (ROA)
of 20.33 %
which means that it generated profit of $20.33 on every $100 spent on asset. This is normal as compared to the sector avarege.
The company has accumulated 20.23 M in total debt with debt to equity ratio (D/E) of 0.49 which is about average as compared to similar companies. Gefen Biomed Investments Ltd has Current Ratio of 0.58 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Gefen Biomed Investments Ltd engages in the location, screening, and investment in earlystage medical devices and biotechnology companies. Gefen Biomed Investments Ltd (GEFEN) is traded on Tel Aviv Stock Exchange in Israel. It is located in Ashkelon, and employs 12 people.